Comparing the current results to its competitors, Standard Biotools Inc reported Revenue decrease in the 3 quarter 2025 year on year by -55.98 %, despite the revenue increase by the most of its competitors of 4.28 %, recorded in the same quarter.
Standard Biotools Inc , slower than the average decrease reported by the company's competitors of -65.26 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -65.26 %
February 26, 2024
Next Gen Diagnostics and Standard BioTools Partner to Revolutionize Pathogen Sequencing AutomationSOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 - Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose - Unleashing tools to accelerate breakthroughs in human health - and Next Gen Diagnostics have announced a groundbreaking partnership. This long-term agreement aims to revolutionize the automation of sample preparation for pathogen whole genome sequencing, bringing forth a new era of advanced diagnostics.Under this exclusive agreement, Standard BioTools will take the lead in manufacturing the NGD-100, a tailored version of its proprietary microfluidics-based Biomark X9 System, customized specifically for Ne...
Thermo Fisher Scientific Inc operates as a global leader in scientific research and services by delivering an extensive range of high-quality scientific instruments, reagents, consumables, and software solutions tailored to industries such as healthcare, pharmaceuticals, biotechnology, academia, and government. The company enhances its value proposition through a comprehensive suite of services, including laboratory outsourcing, scientific consulting, and data analysis, which help streamline research and development processes for its customers. By leveraging advanced technology and deep industry expertise, Thermo Fisher empowers researchers and organizations to drive innovation and accelerate scientific discovery.
Illumina Inc is a leading company in the genomics sector, focusing on next-generation sequencing technologies that enhance genetic analysis. Their business model encompasses a diverse range of products, including sequencing platforms, reagents, and bioinformatics solutions, which together facilitate comprehensive genomic studies for researchers. By integrating these tools, Illumina supports advancements in fields such as oncology, drug discovery, and personalized healthcare, positioning itself at the forefront of genomic innovation.
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Bio-Rad Laboratories Inc operates as a global leader in life sciences and clinical diagnostics by focusing on the development, manufacturing, and distribution of a diverse array of products and solutions. Their business model emphasizes innovation, providing advanced tools and technologies that empower scientists and healthcare professionals to effectively analyze biological materials. By delivering high-quality solutions, Bio-Rad aims to facilitate scientific breakthroughs and enhance patient care in various healthcare settings.
Qiagen N.V. is a Dutch multinational company that operates in the field of molecular diagnostics and sample preparation technologies. Their business model revolves around developing and manufacturing products and solutions for molecular testing, enabling researchers and healthcare professionals to analyze biological samples and gain insights into diseases and genetic variations. Qiagen N.V. primarily generates revenue through the sale of instruments, consumables, and related services to customers in various market segments including academia, pharmaceuticals, and diagnostics.
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Olink Holding Ab publ's business model revolves around providing innovative and high-quality proteomics solutions. These solutions include proprietary technologies and products that enable researchers to analyze proteins and generate comprehensive protein profiles
Cytek Biosciences Inc is a biotechnology company that specializes in developing advanced flow cytometry solutions. Their business model focuses on providing innovative flow cytometry instruments, reagents, and software to the life science research and clinical markets. By offering comprehensive and high-quality products, Cytek Biosciences aims to meet the needs of researchers and healthcare professionals in studying and analyzing cells for various applications.
Bruker Corporation operates as a manufacturer and supplier of scientific instruments and analytical solutions for a wide range of industries and research fields.
Akoya Biosciences Inc is a company that operates on a biotech business model, providing advanced spatial biology solutions for academic and pharmaceutical researchers. They develop and offer innovative technologies, including imaging systems and reagents, to enable scientists to study and understand complex biological systems at a cellular level.
Astrotech Corp's business model focuses on providing innovative solutions and technologies for a variety of industries, including aerospace and defense.
Avantor Inc's business model revolves around providing a wide range of products, services, and solutions to customers in the life sciences, advanced technologies, and applied materials sectors. They focus on delivering a comprehensive offering, including chemicals, lab equipment, consumables, and customized solutions, to support research, development, and production processes.
Harvard Bioscience Inc's business model revolves around providing advanced tools and technologies to the life sciences research community. They offer a wide range of scientific instruments, equipment, and consumables that are used in various applications such as cell analysis, drug discovery, and next-generation sequencing.
Mettler Toledo International Inc Share Performance
-3.74%
30 Days
Mettler Toledo International Inc
Profile
Mettler Toledo International Inc. operates on a business model that focuses on providing high-quality precision instruments and solutions tailored for various industries, including pharmaceuticals, food production, and laboratory research. The company emphasizes innovation and customer-centric service, delivering advanced technology and software alongside its instruments to enhance operational efficiency and accuracy. Additionally, Mettler Toledo generates recurring revenue through maintenance services, calibration, and consumables associated with its products, fostering long-term relationships with its clients.
Nautilus Biotechnology Inc's business model focuses on using advanced genomics and proteomics technologies to analyze and understand the human proteome.
Singular Genomics Systems Inc is a company that offers next-generation sequencing (NGS) solutions for genomics research. They provide an integrated platform that combines sample preparation, sequencing, and data analysis, enabling researchers to efficiently analyze complex genetic information.
Pressure Biosciences Inc's business model revolves around developing and commercializing advanced pressure-based technologies and products for various industries, including life sciences and biotechnology. Their innovative instruments and systems utilize pressure to effectively control and manipulate biological substances for various applications, such as cell disruption, sample preparation, protein extraction, and other related processes.
Quanterix Corp's business model is centered around developing and commercializing ultra-sensitive digital immunoassay platforms, which enable the detection and measurement of biomarkers with exceptional precision and accuracy.
Rapid Micro Biosystems Inc has a business model centered around providing automated microbial detection and enumeration solutions for pharmaceutical companies, ensuring streamlined and efficient quality control processes. Their innovative technology enables rapid detection of microbial contamination in products, reducing the need for manual intervention and accelerating time-to-results for manufacturers.
Reflect Scientific Inc is a company that primarily focuses on developing and manufacturing environmentally friendly cooling and freezing technologies using its proprietary technology. They aim to provide innovative and efficient solutions for industries such as biotechnology, pharmaceuticals, healthcare, and transportation.
10x Genomics Inc is a biotechnology company that specializes in providing tools and solutions for genomic research. Their business model revolves around developing innovative technologies and platforms to enable scientists and researchers to gain deeper insights into the structure and function of biological systems. They offer products such as single-cell sequencing and spatial transcriptomics to support various areas of genomics research and accelerate discoveries in fields like cancer research, immunology, and neuroscience.
Pacific Biosciences Of California Inc Share Performance
+21.84%
30 Days
Pacific Biosciences Of California Inc
Profile
Pacific Biosciences of California Inc's business model revolves around the development and commercialization of innovative sequencing systems that enable scientists and researchers to study the complexity of biology. They provide high-resolution genetic analysis solutions, offering a comprehensive platform that includes consumables, systems, and data analysis software to support genomic analysis.
Sources:
Standard Biotools Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Standard Biotools Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
